India  

Phase-3 trials find 1-shot chikungunya vaccine safe, effective: Lancet

IndiaTimes Monday, 12 June 2023
The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and provoking an immune response. The study was conducted in the US. Its success will have significant implications for nations like India where chikungunya is endemic.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

You Might Like


Related videos from verified sources

The RSB Show 6-5-23 - Vaccine debate paradigm, Vax legislation stalled, Jeff Pearson, Hydrocephalus, Danny Bonaduce surgery, Gly [Video]

The RSB Show 6-5-23 - Vaccine debate paradigm, Vax legislation stalled, Jeff Pearson, Hydrocephalus, Danny Bonaduce surgery, Gly

TODAY ON THE ROBERT SCOTT BELL SHOW: Vaccine debate paradigm, Vax legislation stalled, Jeff Pearson, Hydrocephalus, Danny Bonaduce surgery, Glyphosate safe levels, ADHD medication warning, Psychotic..

Credit: RumblePublished